Cough and Cold Therapy for Kids

Description

Maple Organics Cough & Cold Therapy for Kids is a soothing and calming cough suppressant specifically formulated for pediatric use. The product is presented in a dosage form of a liquid, with a net weight of 2 ounces (56 grams).

Uses and Indications

This drug is indicated for the temporary relief of cough associated with the common cold.

Dosage and Administration

For children aged 2 years and older, the product should be applied in a thick layer to the throat and chest. If desired, the area may be covered with a warm, dry cloth to enhance the effect. It is recommended that clothing around the throat and chest be loose to facilitate the inhalation of vapors. The application may be repeated up to three times daily or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Administration by mouth is prohibited.

• Application in the nostrils is not recommended.

Additionally, when utilizing this product, it is essential to avoid heating, microwaving, or adding it to hot water or any container that may involve heating water, as this may lead to splattering and potential burns.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a persistent or chronic cough, particularly in cases associated with asthma or accompanied by excessive phlegm (mucus).

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience a cough that persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate an underlying serious condition that requires further evaluation.

Side Effects

Patients using this product should be aware of the following adverse reactions and safety information. This product is intended for external use only and should not be ingested or applied in the nostrils.

In clinical practice, patients are advised to stop use and consult a healthcare professional if they experience a cough that persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. Such symptoms may indicate a serious underlying condition that requires medical evaluation.

Additionally, patients should seek medical advice before using this product if they have a persistent or chronic cough, such as that associated with asthma, or if the cough is accompanied by excessive phlegm (mucus). These conditions may necessitate a different therapeutic approach.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Cough and Cold Therapy for Kids (camphor, menthol, eucalyptus oil). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the product to the throat and chest in a thick layer, with the option to cover the area with a warm, dry cloth to enhance vapor delivery to the nose and mouth. This application may be repeated up to three times daily or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of "Cough and Cold Therapy for Kids" during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative to keep this and all medications out of the reach of children. Should ingestion occur, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

Healthcare professionals are advised to monitor for potential symptoms associated with overdosage, although specific symptoms are not detailed in the provided information. Prompt recognition and management of any adverse effects are crucial in mitigating risks associated with overdosage.

Management procedures may include supportive care and symptomatic treatment as necessary. It is essential for healthcare providers to remain vigilant and prepared to implement appropriate interventions based on the clinical presentation of the patient.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this and all medications out of the reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this product is not intended for oral use and should not be applied in the nostrils. Patients should be counseled to discontinue use and consult a doctor if they experience a cough that persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Additionally, healthcare providers should emphasize that when using this product, it should not be heated, microwaved, or added to hot water or any container where water is heated, as this may cause splattering and result in burns.

Finally, patients should be encouraged to consult a doctor before using this product if they have a persistent or chronic cough, such as that associated with asthma, or if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in a tamper-evident container, and it is essential to verify that the seal is intact prior to use. Proper storage conditions must be maintained to ensure product integrity. Specific temperature ranges and additional handling requirements are not provided; however, general best practices for storage should be followed to preserve the quality of the product.

Additional Clinical Information

The product is administered topically and may be used up to three times daily or as directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cough and Cold Therapy for Kids, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)